Superworth

Iradimed PE ratio IRMD

Share price divided by earnings per share over the last twelve months, since 2015.

Today, Oct 23, 2026
47.9×
10-year median
41.4×
Against its 10-year history
59th
percentile: 0 is its lowest day, 100 its highest
10-year range
12.0× to 431×
Peer median
30.1×

Iradimed's PE ratio is 47.9× as of Oct 23, 2026: a share price of $85.82 against $1.79 of earnings per share over the last twelve months.

That is above its ten-year median of 41.4×, close to the middle of its last ten years.

Over that time it ranged from 12.0× in Feb 2017 to 431× in Jul 2021.

The median for 10 medical instruments and supplies stocks of a similar size is 30.1×.

PE ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far47.9×45.9×62.8×
202559.1×33.0×59.1×
202437.4×29.8×38.7×
202336.8×28.8×46.4×
202227.2×26.9×103×
202196.3×69.7×431×
202071.3×20.6×77.8×
201937.3×28.1×70.3×
201857.8×57.4×365×
2017117×12.0×117×
201616.1×13.3×55.8×
201563.7×59.0×103×

Against its peers

Companies in Medical - Instruments & Supplies nearest Iradimed's size, closest first, today.

Where Iradimed ranks

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Iradimed

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.